Unified Trust Company’s Thermo Fisher Scientific TMO Stock Holding History

Unified Trust Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.07M	Buy	+5,374	New	+$2.95M	0.9%	43

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Unified Trust Company's TMO Position: Q3 2021 in Review

Unified Trust Company opened a new position in Thermo Fisher Scientific (TMO) in Q3 2021: 5,374 shares worth $3.07M. The stake represents 0.9% of the portfolio and ranks #43 among its holdings.

2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

Unified Trust Company held 5,374 shares of Thermo Fisher Scientific worth $3.07M as of Q3 2021.
Thermo Fisher Scientific was a new Unified Trust Company position in Q3 2021.
Thermo Fisher Scientific made up 0.9% of Unified Trust Company's portfolio in Q3 2021, its #43 holding.
2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Unified Trust Company's 13F filing for Q3 2021, filed 23 Nov 2021.